The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 No. 775

PART 16 U.K. Amendment of Part 15 (British Pharmacopoeia)

Amendment of regulation 321 (specified publications) U.K.

218.  In regulation 321(5)—

(a) in sub-paragraph (c), insert “ UK ” before “marketing authorisation”;

[F1 (b) after sub-paragraph (c) insert—

“(ca) an EU marketing authorisation;”.]

Textual Amendments

F1 Reg. 218(b) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 178

Commencement Information

I1 Reg. 218 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1